TrialDrugs & aging2025

Anti-hypertensive Drug Classes and Risk of New-Onset Atrial Fibrillation in Healthy Older Adults: A Post Hoc Analysis of ASPREE Trial.

Zhen Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.